Skip to main content
OpenTrials

Clinical trial condition

Monoclonal Gammopathy of Undetermined Significance

Explore clinical trials studying Monoclonal Gammopathy of Undetermined Significance. Study availability and eligibility vary by location and protocol.

33 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Monoclonal Gammopathy of Undetermined Significance trial results

Completed

Screening to Improve Survival in AL Amyloidosis

NCT04615572

Conditions
Amyloidosis, Blood Protein Disorders, Hematologic Diseases, +16 more
Locations
  • University of California, Irvine Health Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Tufts Medical Center Boston, Massachusetts, United States
View Trial Details
Completed

S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.

NCT00919139

Conditions
Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +25 more
Locations
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States
  • Peninsula Medical Center Burlingame, California, United States
  • University of California Davis Cancer Center Sacramento, California, United States
View all 207 locations
View Trial Details

Related conditions